Haitian Creole-language VISs
Out-of-date

The translations for some VISs on our website are from previously published English-language versions that have since been updated. Unfortunately, IAC is not always able to obtain translations as updates are issued. Please ensure that your patients receive information consistent with the current English-language version of the following VISs.

You are encouraged to distribute the up-to-date English-language VIS at the same time as the translation.

MMR VIS

|

Up-to-date English-language [3/13/08]

• Information was added about MMRV vaccine, tied to the March 14 MMWR, regarding increased risk of certain adverse events, including febrile seizures, with MMRV when compared with MMR and varicella vaccines given separately. Aside from two boxes containing information about MMRV, both VISs are identical to the previous editions.
• The new VISs should be used when MMRV is given; but the existing stocks of the individual MMR and varicella VISs may be used when the vaccines are given separately.

Chickenpox VIS [12/16/98]

|

Up-to-date English-language [3/13/08]

• Section 1: The answer has been rewritten by CDC.
• Section 2: There are now 2 doses; the first dose is 12-15 months and the second dose is 4-6 years.
• CDC added information on MMRV.
• The URL for Vaccine Adverse Event Reporting System (VAERS) has changed to www.vaers.hhs.gov.
• The URL for the National Vaccine Injury Compensation Programs has changed to www.hrsa.gov/vaccincompensation.

DTaP VIS [7/30/01]

|

Up-to-date English-language [5/17/07]

• These translations do not contain the following CDC updates
• The main change is in Section 4, which now mentions Tdap.
• The NVICP and VAERS web addresses have also been updated
• The mortality rate for tetanus in Section 1 changed from 1 out of 10, to 2 out of 10 cases.
• The date changed to 5/17/07.

Hepatitis A VIS [8/04/04]

|

Up-to-date English-language [3/21/06]

• CDC changed the indication to 1 year or older, and has recommended routine use for children.

Hepatitis B VIS

|

Up-to-date English-language [7/18/07]

• On July 18, the CDC posted an interim VIS for hepatitis B. There are minor changes throughout, but the main purpose of the update is to emphasize the birth dose for all children.
• A final version will be developed.

Influenza - Live intranasal VIS

|

Up-to-date English-language [10/4/07]

• Changed to "for healthy people from 2 through 49 years of age." Dated 10/4/07.
• CDC updated the VIS for the 2007-08 season. Only influenza vaccines and the VIS for the 2007-08 season should be used. All influenza vaccines from the previous season have expired.

Meningococcal VIS [10/07/05]

|

Up-to-date English-language [8/16/07]

• The meningococcal VIS has been updated slightly to incorporate ACIP's new recommendation to vaccinate all children & adolescents 11-18 years of age. The new VIS is dated (8/16/07); the change affects only the first 2 paragraphs of Section 3. In the VIS News link on the CDC website they say that providers needn't discard existing stocks of the previous edition, but should be prepared to explain the updated recommendation to their patients if they use the older version.
• The Guillain-Barre Syndrome (second bullet just above section 6) was changed slightly: "a few" was replaced by "some" to reflect the additional cases that were reported.
• Section 5: Under severe problems, CDC added information about a possible connection to Guillain-Barre Syndrome.
• Section 1: CDC changed the words to say, "Of those who live, another 11%-19% lose their arms or legs..."
• Section 3: There are new recommendations for MCV4. CDC has added that meningococcal vaccine is recommended for college freshman living in dormitories and microbiologists who are routinely exposed to meningococcal bacteria.
• Section 4: It says MCV4 is a new vaccine that has not been studied in pregnant women as much as MPSV4 has.
• Section 5: There is some more information about MCV4.

This page was updated on March 13, 2008